Journal
CELLULAR MICROBIOLOGY
Volume 20, Issue 12, Pages -Publisher
WILEY
DOI: 10.1111/cmi.12966
Keywords
-
Categories
Funding
- Centre National de la Recherche Scientifique (CNRS)
- Universite Paul Sabatier-Universite de Toulouse
- Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation
- European Union (H2020)
- Agence Nationale de la Recherche (ANR)
- Fondation Bettencourt-Schueller
- Fondation pour la Recherche Medicale (FRM)
Ask authors/readers for more resources
The pulmonary microbial community, described only a few years ago, forms a discreet part of the human host microbiota. The airway microbiota has been found to be substantially altered in the context of numerous respiratory disorders; nonetheless, its role in health and disease is as yet only poorly understood. Another important parameter to consider is the gut-lung axis, where distal (gut) immune modulation during respiratory disease is mediated by the gut microbiota. The use of specific microbiota strains, termed probiotics, with beneficial effects on the host immunity and/or against pathogens, has proven successful in the treatment of intestinal disorders and is also showing promise in the context of airway diseases. In this review, we highlight the beneficial role of the body's commensal bacteria during airway infectious diseases, including recent evidence highlighting their local (lung) or distal (gut) contribution in this process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available